1-2 of 2
A. Grossi, MD
Close
Sort by
Journal Articles

Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results.

Luigi Gugliotta, MD, S. Bulgarelli, MD, S. Asioli, MD, A. Tieghi, MD, G. Gardini, MD, E. Sabattini, MD, V. Franco, MD, E. Boveri, MD, H. M. Kvasnicka, MD, N. Vianelli, MD, A. Candoni, MD, R. Latagliata, MD, F. Passamonti, MD, S. Rupoli, MD, V. Martinelli, MD, A. Zaccaria, MD, F. Lauria, MD, E. De Biasi, MD, S. Sacchi, MD, M. Gobbi, MD, A. Tabilio, MD, E. Cacciola, MD, R. Cacciola, MD, A. Grossi, MD, P. Mazza, MD, F. Bonifazi, MD, P. Favini, F. Mandelli, MD, M. Baccarani, MD, J. Thiele, MD
Journal: Blood
Blood (2005) 106 (11): 4962.
https://doi.org/10.1182/blood.V106.11.4962.4962
Published: 2005
Journal Articles

PEG Intron Treatment in 90 Patients with Essential Thrombocythemia (ET) Final Report of a Phase II Study.

Luigi Gugliotta, MD, S. Bulgarelli, MD, N. Vianelli, MD, D. Russo, MD, A. Candoni, MD, S. Rupoli, MD, R. Latagliata, MD, S. Sacchi, MD, V. Martinelli, MD, E. De Biasi, MD, A. Bucalossi, MD, S. Mazzotta, MD, A. Tabilio, MD, F. Passamonti, MD, A. Grossi, MD, E. Cacciola, MD, R. Cacciola, MD, E. Pogliani, MD, F. Bonifazi, MD, R. Fanin, MD, P. Leoni, MD, F. Mandelli, MD, A. Zaccaria, MD, F. Lauria, MD, M. Lazzarino, MD, M. Gobbi, MD, A. Bosi, MD, P. Mazza, MD, G. Fincato, MD, P. Favini, MD, M. Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 2600.
https://doi.org/10.1182/blood.V106.11.2600.2600
Published: 2005